Pleno has developed the RAPTOR Hypercoding platform, which enables rapid genomic testing from a single patient sample, delivering results within the same day. This technology addresses the high costs and lengthy workflows associated with traditional genomic testing methods, making advanced diagnostics more accessible and economically viable for clinical labs.
Funding
$88.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AVEMEFounders
Product
Problem
Traditional genomic testing methods are often expensive, complex, and time-consuming, limiting their accessibility and widespread adoption in clinical settings. The lengthy turnaround times and high costs associated with these methods restrict the number of patients who can benefit from advanced diagnostics.
Solution
Pleno has developed the RAPTOR Hypercoding platform to enable rapid and cost-effective genomic testing from a single patient sample, delivering results within the same day. The platform aims to reduce the economic barriers associated with genomic testing, making advanced diagnostics more accessible for clinical labs. By streamlining the workflow and reducing turnaround time, RAPTOR seeks to unlock the vast market potential of clinical genomics across various applications, including oncology and other areas where genomics can improve the quality of care. The technology addresses the limitations of existing platforms like Next Generation Sequencing (NGS), PCR, and Microarrays, which face challenges related to total cost, turnaround time, and workflow.
Target Audience
The primary target audience includes clinical labs seeking to improve the economics and accessibility of genomic testing, as well as healthcare providers aiming to enhance patient care through advanced diagnostics.
Features
- RAPTOR Hypercoding instrument platform for rapid genomic testing
- Single-sample multi-omic analysis
- Same-day results
- Streamlined workflow to reduce turnaround time
- Cost-effective genomic testing